Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A de Wynter

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cytotechnology|November 13, 2008
What is the future for cord blood stem cells?E A de Wynter
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2001
Interest of cord blood stem cellsE A de Wynter, N G Testa
International Journal of Clinical & Laboratory Research|January 1, 1995
CD34 cell separation: from basic research to clinical applicationsG Nadali, E A de Wynter, N G Testa
Bailliere'S Best Practice & Research. Clinical Haematology|September 23, 2000
Properties of peripheral blood and cord blood stem cellsE A de Wynter, A J Emmerson, N G Testa
Transfusion Medicine (Oxford, England)|December 2, 2009
Mesenchymal stem cells from CD34(-) human umbilical cord bloodX Lu, S Alshemali, E A de Wynter, et al.
Stem Cells (Dayton, Ohio)|September 1, 1996
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsetsE A de Wynter, G Nadali, L H Coutinho, et al.
Leukemia|July 18, 2001
NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptorE A de Wynter, C M Heyworth, N Mukaida, et al.
Stem Cells (Dayton, Ohio)|October 10, 1998
Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cellsE A de Wynter, J Durig, M A Cross, et al.
Stem Cells (Dayton, Ohio)|November 20, 2001
Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cellsY J Summers, C M Heyworth, E A de Wynter, et al.
Leukemia|November 1, 1994
Timing of peripheral blood progenitor cell (PBPC) collections during recovery from chemotherapy supported by haematopoietic growth factorM E Van Hoef, I Baumann, C Lange, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cytotechnology|November 13, 2008
What is the future for cord blood stem cells?E A de Wynter
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2001
Interest of cord blood stem cellsE A de Wynter, N G Testa
International Journal of Clinical & Laboratory Research|January 1, 1995
CD34 cell separation: from basic research to clinical applicationsG Nadali, E A de Wynter, N G Testa
Bailliere'S Best Practice & Research. Clinical Haematology|September 23, 2000
Properties of peripheral blood and cord blood stem cellsE A de Wynter, A J Emmerson, N G Testa
Transfusion Medicine (Oxford, England)|December 2, 2009
Mesenchymal stem cells from CD34(-) human umbilical cord bloodX Lu, S Alshemali, E A de Wynter, et al.
Stem Cells (Dayton, Ohio)|September 1, 1996
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsetsE A de Wynter, G Nadali, L H Coutinho, et al.
Leukemia|July 18, 2001
NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptorE A de Wynter, C M Heyworth, N Mukaida, et al.
Stem Cells (Dayton, Ohio)|October 10, 1998
Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cellsE A de Wynter, J Durig, M A Cross, et al.
Stem Cells (Dayton, Ohio)|November 20, 2001
Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cellsY J Summers, C M Heyworth, E A de Wynter, et al.
Leukemia|November 1, 1994
Timing of peripheral blood progenitor cell (PBPC) collections during recovery from chemotherapy supported by haematopoietic growth factorM E Van Hoef, I Baumann, C Lange, et al.
Pageof 3